drugset / Trial / NCT01724658

Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women

NCT01724658 ↗

Phase 2 Completed 70 enrolled Chulalongkorn University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Additional testosterone undecanoate can improve female sexual function in postmenopausal women which one aspects of quality of life. The dose adjustment can reduce incidence of adverse effects and low cost of treatment with effective outcome.

Timeline

Start
2012-06
Primary completion
2013-04
Completion
2013-05

Outcome

Met primary endpoint

paper FSFI scores from the testosterone group were significantly higher than in the placebo group post-treatment (28.6 ± 3.6, 25.3 ± 6.7, respectively, p = 0.04). PMID 26631095 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Undecanoate Small molecule 40 mg Oral

Indications